Financing: 2020 Ends On A High Note For Medtech
A look at financing activity across the medical device and in vitro diagnostics industries, October-December 2020
During Q4, device company fundraising totaled $4.2bn; while in vitro diagnostic firms and research tools players raised $6.1bn.
You may also be interested in...
Nano-X Imaging is on a mission to disrupt the market for X-ray imaging equipment by offering a low-cost medical imaging service to untapped markets through a network of equipment dotted around the world. However, some shareholders are claiming the company mislead investors.
During Q4, biopharmas brought in an aggregate $17.5bn in financing and device company fundraising totaled $1.9bn; while in vitro diagnostic firms and research tools players raised $848m.
The year's biggest M&A deal, along with billion dollar alliances marked out December's dealmaking credentials.